BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35612286)

  • 1. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
    Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
    Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of mirtazapine solid dispersion with different carriers' systems: optimization, in vitro evaluation, and bioavailability assessment.
    Aldeeb RAE; Mahdy MAE; El-Nahas HM; Musallam AA
    Drug Deliv Transl Res; 2023 Sep; 13(9):2340-2352. PubMed ID: 36940079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, optimization and full characterization of mirtazapine loaded aquasomes: a new technique to boost antidepressant effects.
    Hussein LM; Dawaba AM; El-Adawy SA
    Drug Dev Ind Pharm; 2024 Mar; 50(3):206-222. PubMed ID: 38334395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization.
    Mehanna MM; Motawaa AM; Samaha MW
    J Pharm Sci; 2011 May; 100(5):1805-18. PubMed ID: 21374616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
    Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
    Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.
    Wang Z; Chen B; Quan G; Li F; Wu Q; Dian L; Dong Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():5807-18. PubMed ID: 23209366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
    Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
    J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
    Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
    Biswas N
    Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.
    Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
    Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.